Loading…
Loading…
Structured register of government actions in the geoeconomic space — export controls, tariffs, sanctions, FDI screening, subsidies, industrial-policy laws — cross-referenced into the country, minerals, and ETF surface. Charter: docs/IPTM_CHARTER.md.
Severity 1-5 is the qualitative impact rating (1=minor, 5=structural). The bilateral-trade-grounded quant scorer is the next IPTM milestone. RBI (Register Breadth Index) is a complementary structural-breadth indicator from scripts/py/iptm/breadth.py; divergence between RBI and severity is itself informative (high-sev / low-RBI = strategic chokepoint; low-sev / high-RBI = broad but shallow). Every action has at least one primary source URL. Verify-or-don't-file. See also themes, timeline, graph, sankey, map, country exposure, sector exposure, material exposure (+ graph), weekly briefs, portfolio scan, escalation monitor, trans-shipment hubs. Internal triage tools (RSS-poller candidate feed, source-feed health) live under /admin/candidates + /admin/sources. Subscribe via Atom feed (accepts ?country=CN, ?material=lithium, ?issuer=BIS, ?type=export_control, ?etf=SOXX, ?company=NVDA, ?minSeverity=4, ?year=2026, ?q=…) or pull /api/iptm/actions.
On 31 December 2025 Mexico's Secretaría de Agricultura y Desarrollo Rural (SADER) published the Acuerdo setting the Reglas de Operación (operating rules) of the "Fertilizantes para el Bienestar" programme for fiscal year 2026 in the Diario Oficial de la Federación. The programme's budget rises to MXN 18.2 billion for 2026, up from MXN 17.5 billion in 2025 (+4%), and continues direct in-kind fertilizer distribution to small-scale producers of priority staple crops (corn, beans, rice) prioritizing women, Indigenous communities, and producers in the country's most marginalized rural municipalities. Global Trade Alert classifies the programme as carrying both a production-subsidy and a local-content-requirement component, effective 1 January through 31 December 2026.
DOE's Loan Programs Office closed a USD 1.5 billion loan under the Energy Dominance Financing Program to Wabash Valley Resources, LLC to restart and repurpose a coal-gasification plant (idled since 2016) in West Terre Haute, Indiana, converting it into a coal- and petcoke-fed anhydrous ammonia fertilizer facility with 500,000 metric tons/year capacity. Secretary of Energy Chris Wright framed the loan explicitly as reducing US dependence on foreign fertilizer supply by using domestic coal, positioning the plant to supply cost-competitive nitrogen fertilizer to Corn Belt farmers. Global Trade Alert logs the loan as a state-loan intervention.
On 22 July 2025, BNDESPAR — the equity-investment arm of Brazil's national development bank BNDES — approved a BRL 114 million (approx. USD 20.5 million) minority equity subscription in Grupo Santa Clara, a Ribeirão Preto (São Paulo)-based producer of special fertilizers and bioinputs founded in 1997. The deal gives BNDESPAR a 19.9% stake, implying a company valuation near BRL 570 million, and is BNDESPAR's first direct variable-income (equity) operation since the bank reactivated its equity-participation strategy in June 2025 — a decade after its last direct stock investment. Proceeds are earmarked to expand Santa Clara's biofactory in Jaboticabal (SP) and fund the group's growth plan toward BRL 1 billion in revenue by 2030.
The Clean Energy Finance Corporation (CEFC), Australia's government-owned green bank, approved a senior project finance loan of up to USD 47 million to Salt Lake Potash Ltd (ASX/AIM: SO4), part of a USD 138 million syndicated senior debt facility (alongside Taurus Mining Finance Fund No. 2) to build the Lake Way sulphate-of-potash (SOP) brine project near Wiluna, Western Australia. The facility funds construction of Australia's first greenfield SOP brine operation, part-powered by a 5MW solar farm and 2MW battery, targeted at cutting SOP production emissions by more than 30% versus conventional non-brine methods.
The Department of Pharmaceuticals notified the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs), Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) on 21 July 2020 via Gazette Notification, with an outlay of Rs 6,940 crore (~USD 920m) over FY 2020-21 to FY 2027-28. The scheme covers 41 identified critical bulk-drug products across four target segments — fermentation-based (Key Fermentation; Niche Fermentation) and chemical synthesis-based (Key Chemical Synthesis; Niche Chemical Synthesis) — paying 20% incentive on incremental sales for fermentation-based products (years 1-4) tapering to 15% (year 5) and 5% (year 6), and a flat 20% over 5 years for chemically-synthesised products. The stated objective is to reduce India's ~70% bulk-drug import dependence on China by establishing greenfield domestic manufacturing capacity with at least 90% domestic value addition for fermentation products and 70% for chemical-synthesis products.